106 related articles for article (PubMed ID: 34128342)
1. Immune infiltration phenotypes of prostate adenocarcinoma and their clinical implications.
Ma Z; Cheng X; Yue T; Shangguan X; Xin Z; Zhang W; Pan J; Wang Q; Xue W
Cancer Med; 2021 Aug; 10(15):5358-5374. PubMed ID: 34128342
[TBL] [Abstract][Full Text] [Related]
2. Integrating single-cell and bulk RNA sequencing data unveils antigen presentation and process-related CAFS and establishes a predictive signature in prostate cancer.
Wang W; Li T; Xie Z; Zhao J; Zhang Y; Ruan Y; Han B
J Transl Med; 2024 Jan; 22(1):57. PubMed ID: 38221616
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the predictive value of angiogenesis-related genes for prognosis and immunotherapy response in prostate adenocarcinoma using machine learning and experimental approaches.
Wang Y; He J; Zhao Q; Bo J; Zhou Y; Sun H; Ding B; Ren M
Front Immunol; 2024; 15():1416914. PubMed ID: 38817605
[TBL] [Abstract][Full Text] [Related]
4. Roles of m5C RNA Modification Patterns in Biochemical Recurrence and Tumor Microenvironment Characterization of Prostate Adenocarcinoma.
Xu Z; Chen S; Zhang Y; Liu R; Chen M
Front Immunol; 2022; 13():869759. PubMed ID: 35603206
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of obesity related genes signature based on microenvironment phenotypes in prostate adenocarcinoma.
Liang L; Shang J; Zhang Y; Xu Y; Zhouteng Y; Wen J; Zhao Y; Feng N; Zhao R
Aging (Albany NY); 2023 Oct; 15(19):10168-10192. PubMed ID: 37788005
[TBL] [Abstract][Full Text] [Related]
6. Construction of lncRNA/Pseudogene-miRNA Network Based on In Silico Approaches for Glycolysis Pathway to Identify Prostate Adenocarcinoma-Related Potential Biomarkers.
Khorsand M; Mostafavi-Pour Z; Tahmasebi A; Omidvar Kordshouli S; Mousavi P
Appl Biochem Biotechnol; 2024 Apr; 196(4):2332-2355. PubMed ID: 37542606
[TBL] [Abstract][Full Text] [Related]
7.
Fan Y; Ge Y; Niu K; Li Y; Qi LW; Zhu H; Ma G
Front Immunol; 2024; 15():1364329. PubMed ID: 38698844
[TBL] [Abstract][Full Text] [Related]
8. tRNA-Derived RNA Fragments Are Novel Biomarkers for Diagnosis, Prognosis, and Tumor Subtypes in Prostate Cancer.
Liu W; Yu M; Cheng S; Zhou X; Li J; Lu Y; Liu P; Ding S
Curr Oncol; 2023 Jan; 30(1):981-999. PubMed ID: 36661724
[TBL] [Abstract][Full Text] [Related]
9. Identification of Molecular Subtype and Prognostic Signature for Prostate Adenocarcinoma based on Neutrophil Extracellular Traps.
Zheng Y; Sun H; Yang S; Liu W; Jiang G
J Cancer; 2024; 15(9):2678-2690. PubMed ID: 38577608
[No Abstract] [Full Text] [Related]
10. Parkinson's Disease as a Risk Factor for Prostate Adenocarcinoma: A Molecular Point of View.
Liu T; Yang Z; Liu S; Wei J
Gerontology; 2023; 69(8):986-1001. PubMed ID: 36921580
[TBL] [Abstract][Full Text] [Related]
11. Predicting prostate adenocarcinoma patients' survival and immune signature: a novel risk model based on telomere-related genes.
Zheng J; Chen J; Li H; Li Y; Dong W; Jiang X
Discov Oncol; 2024 Jun; 15(1):203. PubMed ID: 38825615
[TBL] [Abstract][Full Text] [Related]
12. Exploration of signature based on T cell-related genes in stomach adenocarcinoma by analysis of single cell sequencing data.
Wang H; An N; Pei A; Sun Y; Li S; Chen S; Zhang N
Aging (Albany NY); 2024 Mar; 16(7):6035-6053. PubMed ID: 38536020
[TBL] [Abstract][Full Text] [Related]
13. Immune response drives outcomes in prostate cancer: implications for immunotherapy.
Meng J; Zhou Y; Lu X; Bian Z; Chen Y; Zhou J; Zhang L; Hao Z; Zhang M; Liang C
Mol Oncol; 2021 May; 15(5):1358-1375. PubMed ID: 33338321
[TBL] [Abstract][Full Text] [Related]
14. Genomic and Immunologic Correlates in Prostate Cancer with High Expression of KLK2.
Paniagua-Herranz L; Moreno I; Nieto-Jiménez C; Garcia-Lorenzo E; Díaz-Tejeiro C; Sanvicente A; Doger B; Pedregal M; Ramón J; Bartolomé J; Manzano A; Gyorffy B; Gutierrez-Uzquiza Á; Pérez Segura P; Calvo E; Moreno V; Ocana A
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396898
[TBL] [Abstract][Full Text] [Related]
15. Single-cell and bulk RNA-sequencing reveals mitosis-involved gene HAUS1 is a promising indicator for predicting prognosis and immune responses in prostate adenocarcinoma (PRAD).
Liu S; Yu Y; Xu J; Wang Y; Li D
Cell Biol Int; 2024 May; ():. PubMed ID: 38818762
[TBL] [Abstract][Full Text] [Related]
16. TP63-TRIM29 axis regulates enhancer methylation and chromosomal instability in prostate cancer.
Sultanov R; Mulyukina A; Zubkova O; Fedoseeva A; Bogomazova A; Klimina K; Larin A; Zatsepin T; Prikazchikova T; Lukina M; Bogomiakova M; Sharova E; Generozov E; Lagarkova M; Arapidi G
Epigenetics Chromatin; 2024 Mar; 17(1):6. PubMed ID: 38481282
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of prognostic marker SPOCK3 affecting malignant progression of prostate cancer and construction of prognostic model.
Luo J; Lai C; Xu X; Shi J; Hu J; Guo K; Mulati Y; Xiao Y; Kong D; Liu C; Xu K
BMC Cancer; 2023 Aug; 23(1):741. PubMed ID: 37563543
[TBL] [Abstract][Full Text] [Related]
18. A Prognostic Model for Prostate Cancer Patients Based on Two DNA Damage Response Mutation-Related Immune Genes.
Wang J; Jiang L; Shang Z; Ye Z; Yuan D; Cui X
Cancer Biother Radiopharm; 2024 May; 39(4):306-317. PubMed ID: 37610864
[No Abstract] [Full Text] [Related]
19. Establishment and validation of an immune infiltration predictive model for ovarian cancer.
Song Z; Zhang J; Sun Y; Jiang Z; Liu X
BMC Med Genomics; 2023 Sep; 16(1):227. PubMed ID: 37759229
[TBL] [Abstract][Full Text] [Related]
20. Tumor-infiltrating immune cell score as an independent prognostic predictor for endometrial carcinoma: Insights from a comprehensive analysis of the immune landscape.
Zhang L; Zhu Q; Zhao Q; Lin X; Song H; Liu H; Zhu G; Lu S; Cao B
Cancer Rep (Hoboken); 2024 Jan; 7(1):e1939. PubMed ID: 38017652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
